WallStreetZenWallStreetZen

NASDAQ: POAI
Predictive Oncology Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

POAI past revenue growth

How has POAI's revenue growth performed historically?
Company
18.24%
Industry
7.53%
Market
17.55%
POAI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
POAI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
POAI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

POAI earnings and revenue history

Current Revenue
$1.8M
Current Earnings
-$14.0M
Current Profit Margin
-785.6%

POAI Return on Equity

Current Company
-105.2%
Current Industry
11.1%
Current Market
188%
POAI's Return on Equity (-105.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when POAI announces earnings.

POAI Return on Assets

Current Company
-71.2%
Current Industry
7.2%
POAI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

POAI Return on Capital Employed

Current Company
-133.61%
Current Industry
9.7%
POAI has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

POAI vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
POAI$1.78M-$13.24M-$13.98M+4.75%N/A
AVGR$7.65M-$16.31M-$18.32M-0.67%N/A
STSS$0.00-$9.13M-$9.84MN/AN/A
LUCY$1.15M-$6.58M-$6.66M+267.87%N/A
GCTK$0.00-$7.09M-$7.10M-100.00%N/A
View Top Medical Stocks

POAI earnings dates

Next earnings date
May 13, 2024

Predictive Oncology Earnings & Revenue FAQ

What were POAI's earnings last quarter?

On Invalid Date, Predictive Oncology (NASDAQ: POAI) reported Q4 2023 earnings per share (EPS) of -$0.85, up 58.13% year over year. Total Predictive Oncology earnings for the quarter were -$3.48 million. In the same quarter last year, Predictive Oncology's earnings per share (EPS) was -$2.03.

If you're new to stock investing, here's how to buy Predictive Oncology stock.

What was POAI's earnings growth in the past year?

As of Q2 2024, Predictive Oncology's earnings has grown year over year. Predictive Oncology's earnings in the past year totalled -$13.98 million.

What is POAI's earnings date?

Predictive Oncology's earnings date is Invalid Date. Add POAI to your watchlist to be reminded of POAI's next earnings announcement.

What was POAI's revenue last quarter?

On Invalid Date, Predictive Oncology (NASDAQ: POAI) reported Q4 2023 revenue of $335.03 thousand up 7.82% year over year. In the same quarter last year, Predictive Oncology's revenue was $363.47 thousand.

What was POAI's revenue growth in the past year?

As of Q2 2024, Predictive Oncology's revenue has grown 18.24% year over year. This is 10.72 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 7.53%. Predictive Oncology's revenue in the past year totalled $1.78 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.